US · CAI
Caris Life Sciences, Inc.
- Sector
- Healthcare · Biotechnology
- Headquarters
- Irving, TX 75039
- Website
- carislifesciences.com
Price · as of 2026-09-03
$25.32
Market cap 6.43B
Price history
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | IC | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | |||||
| 2025 | $18.15 | $28.48 |
USD millions
Line items
USD millions
Line items
USD millions
Line items
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | IC Valuation | Core Valuation | Growth | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | Value | Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| CAI | Caris Life Sciences, Inc. | $22.74 | 6.43B | $28.48 | +25% | -75.26 | 8.88 | 6.31 | 413.29 | 96.97% |
| ABVX | Abivax S.A. | $125.39 | 9.21B | — | — | -21.51 | 15.26 | — | -21.49 | — |
| CORT | Corcept Therapeutics Inco… | $110.69 | 11.97B | $87.88 | -21% | 34.01 | 5.15 | 4.39 | 43.50 | 12.79% |
| CYTK | Cytokinetics, Incorporate… | $78.85 | 9.81B | $28.19 | -64% | -9.18 | -10.93 | 81.88 | -9.82 | 376.56% |
| HALO | Halozyme Therapeutics, In… | $83.59 | 9.91B | $151.75 | +82% | 24.07 | 156.29 | 5.46 | 16.80 | 37.55% |
| JAZZ | Jazz Pharmaceuticals plc | $261.57 | 16.43B | $332.64 | +27% | -30.57 | 2.52 | 2.55 | 127.89 | 4.88% |
| MDGL | Madrigal Pharmaceuticals,… | $514.12 | 11.88B | $129.67 | -75% | -34.62 | 16.56 | 10.41 | -35.35 | 432.05% |
| MRNA | Moderna, Inc. | $56.26 | 22.32B | $16.30 | -71% | -7.25 | 2.36 | 10.52 | -6.49 | -39.23% |
| RNA | Atrium Therapeutics, Inc. | $11.74 | 200.82M | — | — | -4.75 | 1.14 | 12.64 | 0.41 | — |
| RYTM | Rhythm Pharmaceuticals, I… | $110.71 | 7.59B | $28.33 | -74% | -28.89 | 21.03 | 29.92 | -30.40 | 45.83% |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($28.48 ÷ $25.32) − 1 = +12.48% (IC, example).